Insider Trading & Executive Data
Start Free Trial
28 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
IDEX Corporation is a diversified, applied‑solutions manufacturer organized into three reportable segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST) and Fire & Safety/Diversified Products (FSDP). The company sells mission‑critical pumps, meters, microfluidics, seals, optical coatings and fire/rescue equipment to industrial, energy, water, life‑science, medical, fire/rescue, agricultural and retail paint markets, with 2024 sales roughly split FMT 38%, HST 39% and FSDP 23%. IDEX operates a decentralized model of 50+ autonomous subsidiaries, a balanced U.S./international footprint with manufacturing in 20+ countries, and a history of targeted M&A (notably Mott in 2024 and Micro‑LAM in 2025) that materially influences scale and margins. Financially it is a generally short‑cycle business with strong free cash flow conversion (101% of adjusted net income in 2024), adjusted EBITDA margin ~26.7%, and leverage around ~2.1–2.2x after acquisition financing.
Compensation is likely tied to a mix of short‑ and long‑term operational and acquisition‑related metrics rather than pure revenue growth: typical drivers at IDEX include adjusted EBITDA and EBITDA margin, adjusted diluted EPS, organic sales growth, free cash flow conversion, ROIC and successful M&A integration milestones. Given the company’s emphasis on price/cost execution, working capital and short‑cycle inventory management, annual bonuses plausibly include working capital or cash‑flow gates and EH&S/employee engagement measures; filings also show higher amortization and interest from acquisitions, so adjusted (non‑GAAP) metrics are prominent in incentive plan design. Long‑term incentives are likely equity‑based (PSUs tied to TSR, EPS or ROIC targets, RSUs and options) to align management with multi‑year value creation and retention through integration periods; one‑time retention/transaction awards are also common after large acquisitions. Finally, incentive design must account for balance‑sheet targets (leverage and interest coverage) because M&A financing materially affects reported earnings and compensation funding.
Insider activity at IDEX may cluster around M&A events, financing transactions (senior notes, revolver draws), share‑repurchase announcements and quarterly results, because these events materially affect leverage, amortization and adjusted metrics that drive pay. The short‑cycle nature of sales and limited backlog means insiders may trade in response to near‑term operational signals (quarterly organic growth, inventory builds, or semiconductor/energy end‑market commentary) rather than long lead indicators. Expect standard regulatory guardrails: Section 16 reporting, Rule 10b5‑1 plans, blackout windows around earnings and deal closings, and short‑swing profit exposure under Rule 16b; additionally, industry‑specific regulatory developments (health & science approvals, export controls, trade tariffs, and evolving OECD Pillar Two tax rules) can create material non‑public information that restricts trading. Because management compensation is equity‑heavy and M&A‑driven, insiders may both hold to capture future upside from integration and opportunistically sell to diversify after large, stock‑price‑moving transactions.